Evaluation Form

Raptiva

Raptiva Alert - Drug May Cause Irreversible Nerve Damage

If you have used the drug Raptiva for psoriasis, take note - you may be at risk for a rare neurological disease.

The disease is known as PML, short for "progressive multifocal leukoencephalopathy." PML is caused by a virus that affects the central nervous system and causes irreversible damage. The disease is usually fatal and has no known cure.

PML has been seen in Raptiva patients who have used the drug for more than three years. Four Raptiva patients in the U.S. have already developed PML, according to the FDA.

If you are using Raptiva now, you should talk to your doctor about changing to a new therapy. If you or a loved one has been harmed by this dangerous drug, you may be entitled to money damages for your injuries. Call the experienced drug injury team at Brown & Crouppen at 1-866-991-4700 or use our online form for a free consultation about your legal rights.

PML destroys the outer covering of nerve cells, impairing the cells' ability to transmit impulses needed for movement or sensory perception.  Symptoms of PML include weakness or paralysis, vision loss, impaired speech and cognitive deterioration.

Health officials in Europe have already pulled Raptiva from the market because of the extreme dangers it poses. In the United States, the manufacturer has agreed to voluntarily withdraw the drug. It will no longer be available as of June 8, 2009.

Besides PML, other side effects of Raptiva include:

  • Immune system disorders
  • Brain inflammation
  •  Brain damage
  •  Meningitis
  •  Sepsis
  •  Tuberculosis.

If you or a loved one has suffered Raptiva-related harm, you need to hold the drug maker accountable. The attorneys at Brown & Crouppen can help you make informed decisions about your legal rights. Call us Toll-Free at 1-866-991-4700 for your free legal consultation or save time with our online Contact Form.

Send This Page to a Friend Watch Our Videos, Dangerous Drug Lawyers Visit Our Blog, Personal Injury Law Blog Disclaimer, MO Drug Attorneys